Document is current
Any future updates will be listed below
-
Authors
Westlund Gotby, Lovisa E. L. http://orcid.org/0000-0002-1059-6616
Lobeek, Daphne http://orcid.org/0000-0003-1282-0826
Roosen, Joey http://orcid.org/0000-0002-7965-6664
de Bakker, Maarten http://orcid.org/0000-0001-9454-388X
Konijnenberg, Mark W. http://orcid.org/0000-0001-5895-8500
Nijsen, J. Frank W. http://orcid.org/0000-0001-7625-2253
-
Funding
Funding for this research was provided by:
European Fund for Regional Development (00942)
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 4 September 2024
First Online: 26 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: JFWN is co-founder and part time scientific director of Quirem Medical which has been acquired by Terumo Europe NV in July 2020. JFWN is entitled to certain milestone payments from Terumo which are related to Quirem’s financial, operational and regulatory performance in the future. Furthermore, JFWN is inventor on the patents related to radioactive microspheres that are assigned to University Medical Center Utrecht Holding BV, Quirem Medical or BASF Corp. The activities of JFWN within Quirem Medical are approved and supported by the Board of Directors of the Radboudumc. The other authors declare that they have no competing interests.
